共 11 条
- [5] De novo tacrolimus-induced thrombotic microangiopathy in the early stage after renal transplantation successfully treated with conversion to everolimus Pediatric Nephrology, 2015, 30 : 693 - 697
- [7] Correction to: Immunological risk and complement genetic evaluations in early onset de novo thrombotic microangiopathy after living donor kidney transplantation: A Japanese multicenter registry Clinical and Experimental Nephrology, 2023, 27 : 1021 - 1022
- [8] Early Conversion from Tacrolimus to Belatacept in a Highly Sensitized Renal Allograft Recipient with Calcineurin Inhibitor-Induced de novo Post-Transplant Hemolytic Uremic Syndrome CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 2018, 8 (01): : 10 - 19
- [9] Combined effects of CYP3A5*1, POR*28, and CYP3A4*22 single nucleotide polymorphisms on early concentration-controlled tacrolimus exposure in de-novo renal recipients PHARMACOGENETICS AND GENOMICS, 2014, 24 (12): : 597 - 606